journal article·2019-12-04Open access

Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer

Chengjun Jin, Weiming Zhao, Zijian Zhang, Wanpeng Liu

Abstract

Background: Prostate cancer (PC) fearfully impacts men's health. We explored the efficacy and mechanism of circular RNA circZNF609 (circZNF609) on colony formation, viability, apoptosis, migration and invasion and in PC cells.Methods: Colony formation, CCK-8, flow cytometry, migration and invasion assay were respectively used to detect the functions of circZNF609 and microRNA (miR)-186-5p on cell colony ability, viability, apoptosis, migration and invasion. circZNF609 and miR-186-5p expression were changed by cell transfection and tested by RT-qPCR. Moreover, Cleaved-Caspase-3, Cleaved-Caspase-9, matrix metalloproteinase-9 (MMP-9), Vimentin and relate-proteins of cell pathways were examined through Western blot.Results: circZNF609 was highly expressed at PC tissues. circZNF609 declined cell colony ability, viability, migration and invasion and caused apoptosis. Furthermore, circZNF609 negatively regulated miR-186-5p, miR-186-5p inhibitor could reverse impacts of circZNF609. Finally, circZNF609 restrained the YAP1 and AMPK pathways by up-regulating miR-186-5p.Conclusion: Silencing circZNF609 restrained growth, migration and invasion of PC cells by up-regulating miR-186-5p via YAP1 and AMPK pathways.HighlightscircZNF609 is highly expressed in PC tissues;circZNF609 restrains cell growth, migration and invasion;circZNF609 exerts its function by up-regulating miR-186-5p;circZNF609 exerts its function by YAP1 and AMPK signaling pathways.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Circular RNAs in diseases · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology, The First Affiliated Hospital of Harbin Medical University

Department of Reproductive Medicine, The First Affiliated Hospital of Harbin Medical University

Funding

Education Office of Heilongjiang Provincial, China

References (31)

Show source-provided references
1. 10.1111/iju.1339710.1111/iju.13397 ↗
2. 10.1038/aja.2013.3710.1038/aja.2013.37 ↗
3. Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med. Life. 2017;10:5–12.
4. 10.21149/spm.v58i2.779710.21149/spm.v58i2.7797 ↗
5. 10.1016/S0090-4295(98)00245-310.1016/S0090-4295(98)00245-3 ↗
6. 10.1080/15476286.2015.102027110.1080/15476286.2015.1020271 ↗
7. 10.1038/cddis.2017.44010.1038/cddis.2017.440 ↗
8. 10.1186/s12943-017-0663-210.1186/s12943-017-0663-2 ↗
9. 10.1016/j.molcel.2017.02.01710.1016/j.molcel.2017.02.017 ↗
10. Zhu L, Liu Y, Yang Y, et al. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci. 2019;23:2817–2826.
11. Cai Y, Yu X, Hu S, et al. A brief review on the mechanisms of miRNA regulation. GPB. 2009;7:147–154.
12. 10.1073/pnas.040443210110.1073/pnas.0404432101 ↗
13. 10.1146/annurev-pathol-012513-10471510.1146/annurev-pathol-012513-104715 ↗
14. 10.1016/j.jbior.2014.09.01310.1016/j.jbior.2014.09.013 ↗
15. 10.1016/j.abb.2018.01.00210.1016/j.abb.2018.01.002 ↗
16. 10.3727/096504017X1495394867543010.3727/096504017X14953948675430 ↗
17. 10.1186/s12885-018-4258-010.1186/s12885-018-4258-0 ↗
18. Bezrukov EA, Rapoport LM, Shpot EV, et al. Prostate cancer of high oncological risk. Current trends in diagnosis and surgical treatment. Urologiia (Moscow, Russia: 1999). 2017;4:129–134.10.18565/urology.2017.4.129-134 ↗
19. 10.2147/CMAR.S17477810.2147/CMAR.S174778 ↗
20. 10.18632/oncotarget.1915410.18632/oncotarget.19154 ↗
21. 10.12659/MSM.90800910.12659/MSM.908009 ↗
22. 10.1002/jcp.2774410.1002/jcp.27744 ↗
23. Tian J, Shen R, Yan Y, et al. miR-186 promotes tumor growth in cutaneous squamous cell carcinoma by inhibiting apoptotic protease activating factor-1. Exp Ther Med. 2018;16:4010–4018.
24. Hua X, Xiao Y, Pan W, et al. miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3. Am J Cancer Res. 2016;6:1650–1660.
25. 10.1038/ncomms1360810.1038/ncomms13608 ↗
26. Sugiyama M, Takahashi H, Hosono K, et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol. 2009;34:339–344.
27. 10.3892/mmr.2015.400510.3892/mmr.2015.4005 ↗
28. 10.1021/jf301692710.1021/jf3016927 ↗
29. 10.1016/j.bbrc.2018.05.00610.1016/j.bbrc.2018.05.006 ↗
30. Zhou GK, Zhang GY, Yuan ZN, et al. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma. Eur Rev Med Pharm Sci. 2018;22:8772–8780.
31. 10.1016/j.cellsig.2013.07.01710.1016/j.cellsig.2013.07.017 ↗